- Home
- TXMD vs BCG Comparison
TXMD vs BCG Comparison
Compare TXMD & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXMD | BCG |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | N/A | 150 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 24.4M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | TXMD | BCG |
|---|---|---|
| Price | $2.07 | $1.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.5K | 17.3K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,761,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $209.00 | ★ $56.15 |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.99 | $1.36 |
| 52 Week High | $2.95 | $3.44 |
Technical Indicators
Market Signals| Indicator | TXMD | BCG |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 42.49 |
| Support Level | $2.07 | $1.36 |
| Resistance Level | $2.13 | $1.64 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 71.11 | 25.00 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
About BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.